BDX vs MCK vs STVN Stock Comparison

Becton Dickinson, Mckesson and Stevanato Group S.p.A Prices as of Oct 27, 2026 Peers: Industry group
BDX Becton Dickinson & Co
$194.95 +6.1% 1M +4.2% 1Y
Market cap
$53.10B
P/E
56.9x
Revenue (TTM)
$23.25B
Div. yield
2.15%
Medical Supplies Healthcare
4 wins
MCK Mckesson Corp
$967.03 +11.6% 1M +19.2% 1Y
Market cap
$112.75B
P/E
25.0x
Revenue (TTM)
$410.98B
Div. yield
0.35%
Drug Distribution Healthcare
7 wins
STVN Stevanato Group S.p.A.
$19.61 -7.5% 1M -24.5% 1Y
Market cap
$5.94B
P/E
34.1x
Revenue (TTM)
$1.43B
Div. yield
0.25%
Medical Supplies Healthcare
1 win

Head to Head

12 decided of 12

Mckesson leads on 7 of the 12 questions below (Mckesson 7, Becton Dickinson 4, Stevanato Group S.p.A 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBDXMCKSTVNLeader
Larger companyMarket capitalisation $53.10B $112.75B $5.94B MCK
Cheaper on earningsLower P/E, profitable companies only 56.9x 25.0x 34.1x MCK
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.0x 20.5x 29.7x BDX
Faster revenue growthRevenue growth, trailing twelve months +17.4% +8.8% +14.8% BDX
More profitableNet margin, trailing twelve months 4.0% 1.1% 11.0% STVN
Better return on capitalReturn on invested capital 5.3% 107.9% 7.2% MCK
Less leveragedLower net debt / EBITDA 3.2x 0.6x 1.2x MCK
Higher dividend yieldTrailing dividend yield 2.15% 0.35% 0.25% BDX
Better 1-year returnPrice return, last 12 months +4.2% +19.2% -24.5% MCK
Better 5-year returnAnnualised price return, 5 years -4.0%/yr +36.4%/yr -5.1%/yr MCK
Less volatileAnnualised volatility, 1 year 31.9% 30.7% 45.6% MCK
Higher overall scoreMean of the five percentile scores vs peers 68/100 57/100 67/100 BDX

Percentile Scorecard

BDXMCKSTVN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBDXMCKSTVN
Valuation 90 #23 of 227 50 #13 of 25 81 #44 of 227
Growth 49 #113 of 219 65 #9 of 24 58 #92 of 219
Profitability 79 #45 of 206 61 #10 of 24 82 #39 of 206
Financial Health 27 #175 of 238 52 #13 of 26 72 #68 of 238
Shareholder Returns 96 #7 of 134 57 #7 of 15 41 #80 of 134
Overall 68 57 67
  • BDX ranked among 247 companies in Medical Devices and Diagnostics
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • STVN ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBDXMCKSTVNSPY
1 month +6.1%+11.6%-7.5% -0.2%
3 months +17.2%+8.7%-2.6% +3.9%
6 months +30.4%+15.8%+21.0% +8.2%
Year to date +0.5%+17.9%-2.5% +12.9%
1 year +4.2%+19.2%-24.5% +12.3%
3 years -22.5%+115.8%-31.7% +87.4%
3 years, per year -8.2%+29.3%-12.0% +23.3%
5 years -18.3%+371.7%-23.2% +67.9%
5 years, per year -4.0%+36.4%-5.1% +10.9%
10 years +16.6%+502.5%— +261.1%
10 years, per year +1.5%+19.7%— +13.7%

Risk

MeasureBDXMCKSTVNSPY
Volatility, 1Y 31.9%30.7%45.6% 12.7%
Downside volatility, 1Y 33.0%27.4%44.7% 12.7%
Beta vs S&P 500, 1Y 0.34-0.271.12 1.00
Return / volatility, 1Y 0.130.62-0.54 0.97
Max drawdown, 5Y -50.4%-27.2%-62.2% -25.4%
From 52-week high -7.2%-6.1%-24.5% -1.2%
52-week high $210.02$1,030.18$25.98 $779.14
52-week low $140.71$725.17$13.43 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBDXMCKSTVN
P/E now vs peer median 56.9xmedian 29.6x 25.0xmedian 23.9x 34.1xmedian 29.6x
P/S now vs peer median 2.3xmedian 2.9x 0.3xmedian 0.3x 4.2xmedian 2.9x
EV/EBITDA now vs peer median 13.9xmedian 17.4x 16.2xmedian 13.4x 18.4xmedian 17.4x
P/FCF now vs peer median 16.6xmedian 22.3x 17.6xmedian 15.5x 10.0xmedian 22.3x
P/B now vs peer median 2.2xmedian 2.3x -26.6xmedian 2.5x 3.4xmedian 2.3x
PEG now vs peer median -3.90median 1.04 2.09median 1.34 -127.14median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBDXMCKSTVN
Revenue $23.25B $410.98B $1.43B
Gross profit $10.91B $14.96B $416.82M
Operating income $2.48B $6.50B $233.97M
Net income $941.00M $5.30B $157.06M
Free cash flow $3.20B $6.42B $592.88M
R&D $1.37B – $29.75M
EPS (diluted) $3.42 $38.52 $0.58
Cash & equivalents $708.00M $5.16B $89.82M
Total debt $72.81B $9.73B $2.11B
Shares (diluted) 275.16M 119.20M 272.96M
Enterprise value $50.25B $99.21B $5.38B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBDXMCKSTVN
P/E 56.9x 25.0x 34.1x
P/FCF 16.6x 17.6x 10.0x
P/Operating cash flow 13.4x 16.5x 20.5x
P/S 2.3x 0.3x 4.2x
P/B 2.2x -26.6x 3.4x
P/Tangible book 2.2x -13.7x 3.4x
EV/EBITDA 13.9x 16.2x 18.4x
EV/EBIT 27.9x 18.1x 27.1x
EV/Revenue 3.0x 0.3x 4.4x
EV/FCF 21.6x 18.3x 10.7x
EV/Operating cash flow 17.5x 17.1x 21.9x
PEG (3Y EPS CAGR) -3.90 2.09 -127.14

Growth

14 metrics
MetricBDXMCKSTVN
Revenue growth (1Y) 17.4% 8.8% 14.8%
Revenue CAGR (3Y) 6.9% 13.1% 9.8%
Gross profit growth (1Y) 23.7% 11.2% 19.4%
Gross profit CAGR (3Y) 8.5% 6.6% 6.2%
Operating income growth (1Y) 13.0% 46.6% 17.2%
Operating income CAGR (3Y) 3.3% 13.5% 4.5%
Net income growth (1Y) -40.6% 58.1% 7.5%
Net income CAGR (3Y) -17.3% 10.7% 0.8%
EPS growth (1Y) -38.0% 52.8% 6.7%
EPS CAGR (3Y) -14.6% 12.0% -0.3%
Operating cash flow growth (1Y) 43.5% 4.7% 30.4%
Operating cash flow CAGR (3Y) 14.5% 10.7% 32.9%
Free cash flow growth (1Y) 54.2% 6.8% 17.2%
Free cash flow CAGR (3Y) 22.5% 11.3% 8.0%

Profitability

14 metrics
MetricBDXMCKSTVN
Gross margin 46.9% 3.6% 29.2%
EBITDA margin 21.4% 1.8% 24.1%
Operating margin 10.7% 1.6% 16.4%
Pretax margin 8.4% 1.6% 15.7%
Net margin 4.0% 1.1% 11.0%
FCF margin 13.8% 1.6% 41.5%
Operating cash flow margin 17.0% 1.7% 20.3%
Return on equity 3.9% – 8.9%
Return on assets 1.9% 6.2% 5.3%
Return on invested capital 5.3% 107.9% 7.2%
Return on capital employed 6.0% 43.4% –
Asset turnover 0.5x 4.8x 0.5x
Cash conversion (OCF / net income) 4.2x 1.3x 1.8x
Stock comp / revenue 1.2% – –

Financial Health

11 metrics
MetricBDXMCKSTVN
Debt / assets 33.1% 11.0% 17.0%
Debt / equity 0.7x -2.3x 0.3x
Net debt / EBITDA 3.2x 0.6x 1.2x
Debt / FCF 5.2x 1.5x 0.9x
Liabilities / assets 51.9% 104.8% 40.8%
Equity / assets 48.1% -4.8% 59.2%
Interest coverage 4.2x 23.6x 14.9x
Current ratio 0.9x 0.9x –
Quick ratio 0.3x 0.5x –
Cash ratio 0.1x 0.1x –
Altman Z-score 2.28 5.89 –

Shareholder Returns

7 metrics
MetricBDXMCKSTVN
Dividend yield 2.2% 0.4% 0.3%
Net buyback yield 4.7% 5.9% –
Shareholder yield 6.9% 6.2% 0.3%
Payout ratio (earnings) – 7.4% –
Payout ratio (FCF) – 6.1% –
Dividend growth (1Y) – 11.3% –
Dividend CAGR (3Y) – 10.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBDXMCKSTVN
Forward P/E 15.0xFY2026 20.5xFY2026 29.7xFY2026
EPS, next fiscal year $12.99FY2026 $47.15FY2026 $0.66FY2026
EPS growth, next FY +14.8%FY2026 +20.6%FY2026 +4.8%FY2026
EPS growth, the year after -2.9% +11.0% +15.2%
Revenue, next fiscal year $18.11BFY2026 $444.47BFY2026 $1.46BFY2026
Revenue growth, next FY -17.1%FY2026 +10.2%FY2026 +5.1%FY2026
Revenue growth, the year after +11.6% +1.5% +10.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBDXMCKSTVN
Held by institutions 96.1% 89.1% 16.4%
Institutions holding 1,442 2,009 126
Change in shares held, QoQ +0.6% -0.7% +0.4%
Institutions buying 688 881 61
Institutions selling 543 791 52
Buyers to sellers 1.27 1.11 1.17

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BDXMCKSTVN
BDX 1.00 0.24 0.22
MCK 0.24 1.00 -0.06
STVN 0.22 -0.06 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BDX, MCK and STVN?

Mckesson (MCK) is the largest by market capitalisation: Becton Dickinson (BDX) $53.10B, Mckesson (MCK) $112.75B, Stevanato Group S.p.A (STVN) $5.94B.

Which stock is cheaper, BDX, MCK and STVN?

Mckesson (MCK) trades on the lowest price-to-earnings ratio (Becton Dickinson (BDX) 56.9x, Mckesson (MCK) 25.0x, Stevanato Group S.p.A (STVN) 34.1x). On next year's consensus earnings, Becton Dickinson (BDX) is cheapest (Becton Dickinson (BDX) 15.0x, Mckesson (MCK) 20.5x, Stevanato Group S.p.A (STVN) 29.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Becton Dickinson (BDX) grew revenue fastest over the trailing twelve months: Becton Dickinson (BDX) +17.4%, Mckesson (MCK) +8.8%, Stevanato Group S.p.A (STVN) +14.8%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (Becton Dickinson (BDX) 4.0%, Mckesson (MCK) 1.1%, Stevanato Group S.p.A (STVN) 11.0%). On return on invested capital, Mckesson (MCK) leads (Becton Dickinson (BDX) 5.3%, Mckesson (MCK) 107.9%, Stevanato Group S.p.A (STVN) 7.2%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Becton Dickinson (BDX) +4.2%, Mckesson (MCK) +19.2%, Stevanato Group S.p.A (STVN) -24.5%. Over five years, Mckesson (MCK) compounded fastest (Becton Dickinson (BDX) -4.0%/yr, Mckesson (MCK) +36.4%/yr, Stevanato Group S.p.A (STVN) -5.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Becton Dickinson (BDX) has the highest dividend yield: Becton Dickinson (BDX) 2.15%, Mckesson (MCK) 0.35%, Stevanato Group S.p.A (STVN) 0.25%.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Becton Dickinson (BDX) 31.9%, Mckesson (MCK) 30.7%, Stevanato Group S.p.A (STVN) 45.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BDX, MCK and STVN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.